Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research
西北核心临床研究站点:艾滋病毒/艾滋病研究的跨组学
基本信息
- 批准号:10371187
- 负责人:
- 金额:$ 386.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-10 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemActive SitesAddressAdvocacyAgingBasic ScienceBehaviorBig DataBiological AssayBiological FactorsBiological MarkersBiological ProcessBiologyBloodBlood specimenCatalogsCellsChronicClinicalClinical ResearchCohort StudiesCollaborationsCollectionCommunitiesComplementComplexCountyDataData AnalysesData CollectionData SetDevelopmentDiagnosisDiseaseDisease OutcomeDisease modelEnrollmentEnsureEpidemicEventFundingGene ExpressionGene Expression ProfileGenesGeneticGenetic DeterminismGenetic RiskGenomeGenotypeGoalsHIVHIV InfectionsHealthHealth Insurance Portability and Accountability ActHealth PolicyHealthcareHeritabilityHospitalsHumanImageImmune System DiseasesImmune responseInfectionInflammationInflammation MediatorsInflammatoryInformation TechnologyInformed ConsentInfrastructureInterdisciplinary StudyKnowledgeLaboratoriesLeadLeadershipLinkMaintenanceMeasuresMedical RecordsModelingModeling of Functional InteractionsMolecular ProfilingOffice of Administrative ManagementOutcomeParticipantPathogenicityPathway AnalysisPathway interactionsPatternPersonsPharmaceutical PreparationsPhenotypePlayPoliciesPolicy DevelopmentsPractice GuidelinesPrecision Medicine InitiativePredispositionProceduresProductionPropertyProspective StudiesProtocols documentationPsychosocial FactorPublic HealthQuality ControlRecording of previous eventsReportingReproducibilityResearchResearch PriorityResearch Project GrantsResourcesRiskRoleRunningScienceScientific Advances and AccomplishmentsScientistSeverity of illnessSignal PathwaySignaling ProteinSystemTestingTissuesTrainingUnited States National Institutes of HealthUniversitiesVariantVirusVirus ReplicationWorkadjudicateadjudicationbaseclinical careclinical research siteco-infectioncohortcomorbiditycookingdata integrationepidemiology studyflexibilityfollow-upfunctional genomicsgenetic variantgood laboratory practiceimmune activationimprovedinclusion criteriainnovationinsightmicrobiomemultidisciplinarynew therapeutic targetnext generationnovelparticipant enrollmentparticipant retentionpatient engagementpredictive modelingprogramsprotein expressionprotein protein interactionquality assurancerepositoryresponserisk variantsample collectionsocial science researchvaccine developmentvirus host interaction
项目摘要
The Northwestern University and the Ruth M. Rothstein CORE Center of the Cook County Health & Hospitals
System Clinical Research Site (NC CRS) addresses the highest research priorities in HIV/AIDS research
through retention and maintenance of the cohort, collection and repository storage of blood samples, and
development and implementation of the unified science agenda. Through the leadership we provide and the
data and blood samples we collect, the NC CRS actively contributes to core protocols and thematic sub-
studies to characterize the long-term, natural and treated history of HIV infection in a representative cohort of
people at substantial risk of becoming infected with the virus. We strictly adhere to good practice guidelines,
established policies and procedures, and robust quality assurance and quality control measures to ensure the
accuracy, reproducibility, and integrity of the clinical and laboratory data and blood samples. Scientific and
administrative management provides both the flexibility and means to conduct multidisciplinary research
projects as well as the resources to respond rapidly to recent scientific progress. For the past 35 years, we
have maintained a comprehensive portfolio of biomedical and social science research on HIV and its related
coinfections, comorbidities, and other complications. The diversity of the work makes possible a broad and
multidisciplinary view of these high priority topics for understanding the basic biology of HIV, immune
dysfunction and chronic inflammation, and genetic determinants. Scientific questions take full advantage of the
strengths of the cohort, namely, its duration and the continuity of data and blood samples that timespan
provides. Data and blood samples are available from people before and after infection, before and after
beginning medications, or before and after the development of comorbidities or their complications. Productive
relationships across the combined cohort, as well as other consortia and organizations, have coalesced around
specific issues to advance scientific knowledge, the health of people, and policy development. By capitalizing
on the expertise and unique resources of a multidisciplinary team of experts, we will build on our studies of
genome sequence, patterns of gene and protein expression, and metabolite concentrations and changes
(trans-omics dataset), along with information from people's medical records, to identify genes and pathways
that play a role in disease and determine how they interact with HIV. Hierarchal models that predict the
network behavior that gives rise to a phenotype will unravel the complexity of disease to provide novel and
important insights into biological processes for testing or generating a set of hypotheses about disease
mechanisms. During the next 7-year funding cycle, the NC CRS will continue support for the cohort and trans-
omics for HIV/AIDS research that complements and extends the NIH Precision Medicine Initiative that
connects genotype and phenotype and aligns with the NIH Big Data Initiative that supports innovative and
transformative approaches to advance understanding of human health and disease.
西北大学和库克县健康与医院的露丝·m·罗斯坦核心中心
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven M Wolinsky其他文献
Steven M Wolinsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven M Wolinsky', 18)}}的其他基金
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research
西北核心临床研究站点:艾滋病毒/艾滋病研究的跨组学
- 批准号:
10223024 - 财政年份:2019
- 资助金额:
$ 386.2万 - 项目类别:
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research
西北核心临床研究站点:艾滋病毒/艾滋病研究的跨组学
- 批准号:
10214768 - 财政年份:2019
- 资助金额:
$ 386.2万 - 项目类别:
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research
西北核心临床研究站点:艾滋病毒/艾滋病研究的跨组学
- 批准号:
9927860 - 财政年份:2019
- 资助金额:
$ 386.2万 - 项目类别:
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research
西北核心临床研究站点:艾滋病毒/艾滋病研究的跨组学
- 批准号:
9912209 - 财政年份:2019
- 资助金额:
$ 386.2万 - 项目类别:
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research
西北核心临床研究站点:艾滋病毒/艾滋病研究的跨组学
- 批准号:
10217306 - 财政年份:2019
- 资助金额:
$ 386.2万 - 项目类别:
A Systems-level Approach to Studying HIV/AIDS Susceptibility and Substance Abuse
研究艾滋病毒/艾滋病易感性和药物滥用的系统级方法
- 批准号:
8321794 - 财政年份:2012
- 资助金额:
$ 386.2万 - 项目类别:
A Systems-level Approach to Studying HIV/AIDS Susceptibility and Substance Abuse
研究艾滋病毒/艾滋病易感性和药物滥用的系统级方法
- 批准号:
8637965 - 财政年份:2012
- 资助金额:
$ 386.2万 - 项目类别:
A Systems-level Approach to Studying HIV/AIDS Susceptibility and Substance Abuse
研究艾滋病毒/艾滋病易感性和药物滥用的系统级方法
- 批准号:
8828647 - 财政年份:2012
- 资助金额:
$ 386.2万 - 项目类别:
A Systems-level Approach to Studying HIV/AIDS Susceptibility and Substance Abuse
研究艾滋病毒/艾滋病易感性和药物滥用的系统级方法
- 批准号:
8794566 - 财政年份:2012
- 资助金额:
$ 386.2万 - 项目类别:
相似海外基金
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 386.2万 - 项目类别:
Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 386.2万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 386.2万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 386.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 386.2万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 386.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 386.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 386.2万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 386.2万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 386.2万 - 项目类别:
Discovery Grants Program - Individual